Day: June 24, 2020

RICHMOND, Va., June 24, 2020 (GLOBE NEWSWIRE) — ALR Technologies Inc. (OTCQB: ALRT) today announces that the ALRT Diabetes Solution will be available to diabetes patients through their private physicians across Singapore. ALRT Diabetes Solution is a diabetes management platform that offers a comprehensive approach to diabetes and includes Bionime’s Rightest GM700SB blood glucose meter and test strips.The partnership with Bionime Corporation (“Bionime”) (TPE:4737) includes Bionime’s marketing team calling on the private physician practices in Singapore and the larger private practice groups. Founded in 2003, Bionime provides best quality products to people with healthcare need and their care givers, so that they can easily manage their daily health.The ALRT Diabetes Solution mitigates and contains diabetes complications by helping...

Polarcus Limited (“Polarcus” or the “Company”) (OSE: PLCS) refers to its announcement dated 14 January 2020 regarding the scheduled redelivery of “Vyacheslav Tikhonov” (the “Vessel”).The Vessel has completed the earlier referenced project in Asia. In light of further project opportunities, the charterers, Sovcomflot, have withdrawn their notice of redelivery. Polarcus will not receive charter hire from 31 May 2020 until startup of a new project anticipated to commence in Q3 2020. Redelivery of the Vessel is now expected to be following completion of the new project, or alternatively, on short notice if no project is awarded for the Vessel in the summer season. ContactsHans-Peter Burlid, CFO+971 50 559 8175hp.burlid@polarcus.com About PolarcusThis information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian...

REDWOOD CITY, Calif., June 24, 2020 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Nasdaq:SLNO), (“Soleno” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today the pricing of the underwritten public offering of 30,303,030 shares of its common stock at a public offering price of $1.65. Soleno has also granted the underwriters a 30-day option to purchase up to 4,545,454 additional shares of common stock, at the public offering price, less underwriting discounts and commissions.  The gross proceeds of the offering are expected to be approximately $50 million, before deducting the underwriting discount and other estimated offering expenses. The closing of the offering is expected to occur on or about June 26, 2020, subject to the satisfaction of...

DAVIS, Calif., June 24, 2020 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that its flagship biofungicide, Regalia, holds more than 25% market share* of the foliar biofungicide segment in California; outperforming direct competitors during January through April 2020.“Regalia’s performance is a testament to its efficacy for managing plant diseases and improving crop health,” said Kevin Hammill, chief commercial officer for Marrone Bio Innovations. “Its performance has been proven on domestic and international specialty crops for more than ten years. While the 2020 fungicide market in California is down overall, we are pleased to see that when growers used a biofungicide, they chose Regalia more often than direct...

TORONTO, June 24, 2020 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB and OTC: TDRYD) (“RWB” or the “Company”) is pleased to announce that its investee PharmaCo Inc. continues to execute on their expansion, having been awarded nine (9) new Municipal Marijuana cultivation licenses in June and commencing their first harvest at their Detroit indoor cultivation facility.PharmaCo was awarded five (5) Municipal Class C grow licenses in Spaulding Township and four (4) Municipal Class C grow licenses in Au Gres Township; collectively this represents the right to grow 13,500 plants, subject to final State approvals.In Detroit, planting at the newly commissioned 22,000 square foot indoor facility began earlier this year, and the first plants are now being harvested, while remaining on time and on budget. PharmaCo continues...

MORRISVILLE, N.C., June 24, 2020 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced that Paula Brown Stafford, the Company’s President and Chief Executive Officer, will present a corporate overview at the Life Sciences Investor Forum on Thursday, June 25, 2020 at 2:00 p.m. Eastern.This will be a live, interactive online event where investors are invited to ask the company questions in real-time. The presentation and Q&A session will be webcast live and can be accessed through the Events page of the For Investors section of the Company’s website at https://novan.gcs-web.com/events or at www.lifesciencesinvestorforum.com.If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that...

BERKELEY, Calif., June 24, 2020 (GLOBE NEWSWIRE) — Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand (APRIL) pathways for the treatment of cancer, autoimmune and inflammatory diseases, today announced that the first patient with IgA nephropathy has been dosed in a Phase 1 clinical trial of BION-1301, an investigational humanized IgG4 monoclonal antibody that blocks APRIL binding to both the BCMA and TACI receptors.“We are thrilled to have dosed the first patient with IgA nephropathy in the Phase 1 clinical study of our investigational anti-APRIL antibody, BION-1301,” said Dimitry S.A. Nuyten, M.D., Ph.D., chief medical officer of Aduro. “The data Aduro recently presented from Parts...

WINNIPEG, Manitoba, June 24, 2020 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced that it has been approved for up to $54,750 in funding from the Government of Canada’s CanExport SMEs program. Kane will use this funding to support the marketing costs associated with the U.S. launch of its Human Health anti-biofilm shampoo as well as to support international growth of its Animal Health business.CanExport SMEs is a program delivered by the Trade Commissioner Service (TCS) of Global Affairs Canada in partnership with the National Research Council’s Industrial Research Assistance Program (NRC-IRAP). It provides direct financial assistance to small and medium-sized businesses registered in Canada in order to help them develop new export opportunities and markets.“Having...

4-Star Supplier Excellence Award honors superior quality and performanceGREENSBORO, N.C., June 24, 2020 (GLOBE NEWSWIRE) — Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, today announced that Custom MMIC, which was acquired by Qorvo in February, has been awarded a 4-Star Supplier Excellence Award by Raytheon Technologies’ legacy Integrated Defense Systems business (now Raytheon Missiles and Defense) for 2019 performance. The supplier excellence program was instituted to recognize quality, on-time delivery and commitment to continuous improvement. This is the fourth consecutive year that Custom MMIC received the prestigious honor.  James Klein, president of Qorvo’s Infrastructure and Defense Products (IDP), said, “The 4-Star award is presented by Raytheon’s legacy Integrated Defense Systems...

Includes positive clinical findings from a postcoital test (PCT) human clinical study of Ovaprene®, an investigational hormone-free, monthly contraceptiveSAN DIEGO, June 24, 2020 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced the publication of a literature review article by Biology of Reproduction that identifies and reviews 10 postcoital test (PCT) studies of vaginal contraceptives involving 9 test products, including Daré’s investigational hormone-free, monthly contraceptive Ovaprene, currently under a license agreement with Bayer for commercialization in the U.S.The literature review was conducted with the support and participation of the Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas, and Daré Bioscience. Based on...